top of page
VAMA Board
Admin
The Board of Directors
More actions
Profile
Join date: Jun 2, 2025
Posts (4)
Oct 22, 2025 ∙ 2 min
Following the “Uber Model” to Repurpose Drugs for Value Added Success
Our recent participation in the European Repurposing 4 EU conference in Barcelona highlighted significant challenges and opportunities in the development and commercialization of repurposed drugs, particularly within the EU and U.S. markets. This post explores how advanced technologies—especially those leveraging artificial intelligence (AI)—can transform the value proposition for repurposed drugs, with a focus on regulatory, reimbursement, and distribution strategies enabled by the 505(b)(2)...
89
0
Jul 9, 2025 ∙ 2 min
Member Exclusives: Accessing Expertise on Value-Added Medicines
Welcome to our new website and a whole new world where expertise in value added medicines is just a click or request away. The 505(b)(2)...
17
0
Jul 3, 2025 ∙ 2 min
Advancing 505(b)(2) Development: Top Strategies Revealed
Are you involved in the development and marketing of value-added medicines like 505(b)(2)s? If so, you may find the latest insights on...
33
0
bottom of page